Sectoral Asset Management Inc Homology Medicines, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $380,513 - $635,081	-38,281 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$12.5 - $22.04 $67,500 - $119,016	-5,400 Reduced 12.36%	38,281 $595,000
Q4 2019 Feb 12, 2020	SELL	$11.42 - $22.19 $350,594 - $681,233	-30,700 Reduced 41.27%	43,681 $904,000
Q3 2019 Nov 14, 2019	BUY	$14.74 - $22.28 $1.1 Million - $1.66 Million	74,381 New	74,381 $1.35 Million
Q4 2018 Feb 12, 2019	SELL	$18.39 - $26.3 $2.64 Million - $3.77 Million	-143,487 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$16.49 - $21.55 $1.34 Million - $1.76 Million	-81,513 Reduced 36.23%	143,487 $2.93 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $4.2 Million - $4.21 Million	225,000 New	225,000 $4.21 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.